Advantis Corp., has acquired a 25% stake in US-based pain management and physical therapy company Sequence Therapy, LLC, which sees an exponential growth in revenue, from the current $0.5m a year, with the addition of the app-based revenue.
The acquisition will help Advantis to provide license-based digital application technology and achieve long-lasting results in the treatment of chronic pain.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Madrigal Pharmaceuticals, Inc. has announced a definitive agreement to merge with Synta Pharmaceuticals Corp.
The all-stock transaction will result in the merger of Madrigal with Synta’s wholly-owned subsidiary Saffron Merger Sub, Inc.
The merged entity will focus on developing small-molecule drugs to meet major unmet needs in cardiovascular-metabolic diseases and non-alcoholic steatohepatitis.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
